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ARTICLE
Antimicrobial resistance, inﬂammatory responses:
a comparative analysis of pathogenicities,
knowledge hybrids and the semantics
of antibiotic use
Helen Lambert1, Meixuan Chen1 & Christie Cabral2
ABSTRACT Antimicrobial resistance is widely recognised as a global threat to human health.
This paper explores the mobilisation of biomedical concepts and technologies within local
semantic registers and addresses the implications of translation and knowledge complexity for
attempts to mitigate the problem of antibiotic resistance. In China, antibiotics are frequently
prescribed for common complaints and are widely available without prescription. Drawing on
ﬁeld research in three rural counties of one province, we show that current patterns of antibiotic
use are the result of sociocultural, economic and systems drivers within a medical context that
draws on precepts from both biomedicine and Chinese medical knowledge. Comparative analysis
with European settings suggests that pathogenicity, the set of explanatory frameworks regarding
the production of disease, varies socio-temporally in the causal mechanisms that are prioritised.
Incorporated within diagnostic strategies that direct treatment towards the bodily response to
infection rather than to the infecting pathogen, ‘anti-inﬂammatory medicine’ as the popular term
for antibiotics in parts of Asia foregrounds physiological process over microbial invasion. We
examine the articulation of biomedical knowledge paradigms within a non-Pasteurian milieu in
relation to socio-historical process, including hybridisation between ontologically distinct medical
traditions and the heterogeneity of scientiﬁc knowledge claims that underpin contemporary
practices of antibiotic prescribing. We conclude that the concept of inﬂammation functions as a
boundary object which effectively mediates the interfaces between popular knowledges, bio-
medical sciences and local medical practices. Our analysis may have wide relevance because
popular and scientiﬁc understandings of inﬂammation alike draw on metaphors grounded in
universal sensory experience that provides a common basis for culturally diverse conceptual
elaboration. Situated understandings of inﬂammation and associated treatment preferences
constitute a contextually coherent response to available medical technologies in community
health care. Our analysis also calls into question simplistic interpretations of antibiotic use for
non-bacterial conditions as deriving from lack of education or public awareness and suggests a
need to reconsider current public health knowledge translation strategies.
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Antimicrobial resistance (AMR) and speciﬁcally, resistanceto common antibiotics of bacterial pathogens that causeillness in humans, has been identiﬁed as a pressing pro-
blem for global health and development (World Health Organi-
zation, 2015, 2016). Research funders and development agencies
acknowledge that AMR is a multifaceted, One Health issue
requiring multi-sectoral action and research across the life,
medical and social sciences (Jasovsky ́ et al., 2016; Mendelson
et al., 2016; Das and Horton, 2016; Dar, 2016; Holmes et al., 2016;
Laxminarayan et al., 2016; Robinson et al., 2016). The therapeutic
use of antibiotic use in human health care is generally agreed to
be a key driver of AMR (O’Neill, 2016) and reducing unnecessary
or ‘inappropriate’ (i.e. where not warranted by the presence of
bacterial infection) therapeutic use is thus a core component of
global and national action plans to tackle AMR, alongside mea-
sures to prevent infection and to increase the production of new
antibiotics and diagnostic tests for bacterial infection (World
Health Organization, 2015).
The concept of ‘antibiosis’, with its implications for under-
standing and shaping the character of human–microbe relations
as necessarily antagonistic, serves as our point of departure for
this case-based enquiry into some embedded assumptions that
orient current global health strategies and narratives regarding
AMR.1 Pathogenicity, or the potential to produce disease, has
been characterised, following the political economy of health
approach of medical anthropologists, such as Paul Farmer and
Merrill Singer, as ‘made through the particular conﬁgurations of
microbes, bodies, environments and so on’ (Hinchliffe et al.,
2017, p. 17). The ‘anti-biotic’, that which is against life, literally
encapsulates the biomedical response to the microbial pathogen.
However, ecological paradigms that acknowledge the complexity
and heterogeneity of interactions between individual organisms,
immune responses and environmental conditions in the pro-
duction of disease are also well established in the biosciences,
including biomedicine (Pickstone, 2000), as well as in Asian
medical traditions (e.g. Zimmerman, 1982). In biomedicine,
which of these dimensions comes to the fore or is subordinated in
representations of pathogenicity varies across historical periods
(Pickstone, 2000) and biogeographical ‘disease situations’ (Hin-
chliffe et al., 2017). Across the multiple sciences that concern
themselves with antimicrobial resistance, how AMR should be
enfolded within understandings of pathogenicity is currently
contested; scientiﬁc claims (regarding, for instance, the relative
importance of environmental transmission versus antibiotic
consumption in driving resistance, or the scale of the role of
antibiotics in agriculture, or the signiﬁcance of probiotics) have
yet to be settled (Latour, 1987).
Nevertheless, in the ‘Pasteurian world’ (Paxson, 2008) of Euro-
American society that was brought into being by the discovery of
microbes (Latour, 1988), and despite the recent emergence of
‘post-Pasturian’ (Paxson, 2008, p. 15) interest in the microbiome,
it is germ theory and the characterisation of organism interaction
as antibiosis that dominates social and global health narratives of
AMR. At the science–society interface, the complex, unsettled
questions and uncertainties entailed in accounting for AMR as
phenomenon and process across multiple scientiﬁc disciplines are
rarely visible. Public-facing explanations present largely unicausal
accounts of pathogenicity that centre on the invasive microbial
pathogen as increasingly invulnerable threat. Our case study of
everyday antibiotic use in an Asian setting reveals a differently
conﬁgured mobilisation of medical knowledges that, through the
anthropological comparative method, enables the articulation of
possible alternatives. We build on anthropological evidence on
AMR and antibiotics (Rajyowijati and Haak, 2003; Haak and
Radyowijati, 2010; Orzech and Nichter, 2008; Chandler and
Hutchison, 2016; Cabral et al., 2014b, 2015) and more broadly on
the therapeutic use of pharmaceuticals (Das and Das, 2006; Van
Der Geest et al., 1996; Nichter and Vuckovic, 1994; Vuckovic,
1999; Whyte et al., 2003; Van Der Geest and Whyte, 1988), as
well as on scholarship in the sociology and history of science and
medicine, to demonstrate how patterns of antibiotic prescribing
in rural China emerge from certain knowledge-practice conﬁg-
urations in the diagnosis and treatment of illness within the broad
ambit of biomedicine as locally practised.
This paper reports on ﬁndings from an interdisciplinary col-
laborative research project investigating drivers of antibiotic use
in rural areas of one province in China. There is considerable
evidence that antibiotics are overused in the healthcare system
(Yin et al., 2013; Li et al., 2012; Zhang et al., 2006; Cui et al., 2017;
Jin et al., 2011) of China. Despite government healthcare reforms
that have been linked to reductions in prescribing at county and
higher level public hospitals (Sun et al., 2015) and a series of
policies and initiatives that have begun to modify antimicrobial
use (Wang et al., 2016; Zhang et al. 2018), China is estimated to
have some of the highest rates of AMR in the world (Cui et al.,
2017; Center for Disease Dynamics, 2018). Legislation to prevent
over the counter (OTC) sales of antibiotics is in place, but anti-
biotics can often still be obtained via direct OTC purchasing from
pharmacies as well as via medical prescription.
This paper sheds light on current patterns of antibiotic use by
exploring the complex relationships between biomedical and
other understandings of infection, antibiotic prescribing practices,
and the organisation of local health systems. We show how
concepts of infection and inﬂammation are mobilised in rural
medical care and reﬂect on the popular characterisation of anti-
biotics as ‘anti-inﬂammatory’ in relation to measures to ratio-
nalise antibiotic prescribing. We then analyse the working of
biomedical categories into local semantic registers through pro-
cesses of hybridisation and differentiation that have been ongoing
over the past century. By highlighting the range and heterogeneity
of scientiﬁc ﬁelds that contribute to knowledge of antibiotic
action within biomedicine, as well as the semantic complexities
entailed in the translation of this knowledge into everyday
practice, we provide a novel contribution to the growing body of
evidence which problematises simplistic assumptions that pre-
scribing practices which deviate from biomedically orthodox
recommendations necessarily result from ignorance or lack of
awareness. Our title plays on the biomedical characterisation of
the ‘inﬂammatory response’, the biochemical reaction to cell
injury by bacteria or other causes, as an appropriate descriptor of
socio-medical situations that may inadvertently exacerbate the
problem of antibiotic resistance. These situations do not, how-
ever, result from either wilful or unknowingly inappropriate
prescribing or consumption, but from socio-historical processes
through which microbial pathogens stand in a different relation
to pathogenicity in local biomedicine than in, for example, the
UK. Our analysis thus provides both a case study in the con-
struction and contextual variability of biomedical knowledge, and
an exemplar of the need to take seriously situated rationalities and
context speciﬁcity when developing antibiotic stewardship mea-
sures (Kakkar et al., 2018).
Study settings and methods
The wider project from which the material presented here is
drawn is an interdisciplinary study to investigate the socio-
cultural, economic and systems drivers of antibiotic use in rural
China and to determine the feasibility of assessing the prevalence
of AMR in rural settings (among outpatients presenting to lower
level health facilities) through microbiological tests.
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The data we present below were collected between 2017 and
2018 in three counties of a province in eastern China (see Zhao
et al. (2019) for full details of the research design). Each ﬁeld area
included one village clinic (the lowest level of the healthcare
system), one township health centre (each of which has oversight
of 4–7 village clinics in the geographical area covered by the
township) and all retail pharmacies (4–8) in each selected
township. Health facilities were selected at random from a list
provided by the provincial Health Authority. The same procedure
was followed to select one village clinic from a list provided by the
township health centre management. In this paper, we draw on
data collected from patients and health professionals who were
recruited in the participating township health centres (3) and
village clinics (3). The province is situated in central eastern
China and has a population of 68.6 million, of whom 57% live in
rural areas. It is a largely agricultural region with high levels of
rural–urban outmigration. Per capita GDP and income rank in
the middle (14th) among all provinces in the nation and its social,
cultural and economic background is representative of over 80%
of the population in China. In terms of ﬁrst-time medical care,
62.9% is at village or community clinics, 17.3%, at township or
community health centres and 13.6% at county level hospitals.
Methods and data collection instruments were piloted in the
ﬁrst ﬁeld area and modiﬁed, where necessary, but since there were
no fundamental changes in research design, data from this ﬁeld
area are included in our analysis. Research was then undertaken
consecutively in two further ﬁeld areas (two clinical facilities and
all pharmacies per area). In village clinics and township health
centres two researchers (a member of academic staff and a
graduate student) stationed at each health facility observed clin-
ical consultations over a 4-month period, recruited consecutive
patients who reported symptoms of respiratory tract infection
(RTI) or urinary tract infection (UTI) into a microbiological
feasibility study for which throat swabs, sputum, or urine samples
(depending on presenting symptom) were taken and conducted
an exit survey with consenting patients. The observations were
undertaken to ensure we had an accurate record of antibiotics
prescribed for subsequent comparison with both our micro-
biological data on antibiotic resistance and with electronic patient
records. We also wanted to be able to compare details of actual
clinical encounters with doctors’ and patients’ subsequent
accounts. An observational template was developed to assist
researchers to record key features of the consultation process,
such as whether and which antibiotics were prescribed, who
initiated prescribing of antibiotics and the precise terms used to
describe them, and how the patient initially presented their health
problem to the doctor. The researchers spent one week stationed
in each facility before commencing recruitment in order to
minimise observer bias. Clinic staff and patients are accustomed
to consultations occurring in a semi-public environment (see next
section) so the researchers did not attract special attention. Only
consultations for which patients gave informed consent are
included in our analysis of observational data. The exit survey was
constructed by creating a set of short open-ended interview
questions, the responses to which were analysed at the end of the
pilot phase and transformed into close-ended questions for ease
of analysis. The exit survey was administered by a researcher to
every enrolled participant immediately following the end of their
clinical consultation, with the primary aim of ascertaining
knowledge of and attitudes to antibiotics (whether patients knew
that they had just been prescribed antibiotics, whether they had
previously used antibiotics for this or a previous illness episode in
the past year, plans for stopping, storing and sharing antibiotics
and familiarity with the concept of antibiotic resistance). Follow-
up in-depth interviews were conducted with a purposive sample
of enrolled patients at their homes 1–2 weeks following their visit
to the health facility and with the doctors at each healthcare
facility towards the end of the study period. The main purpose of
follow-up patient interviews was to obtain more detailed narrative
information regarding key inﬂuences on antibiotic use including
the illness, self-diagnosis and related treatment-seeking beha-
viour, prior use of antibiotics, prompts that led the patient to seek
treatment at the relevant health facility and subsequent illness
trajectory and treatment decisions. Purposive sampling was used
to ensure that our sample included a mix of patients by gender,
age, type of reported infection (RTI or UTI) and roughly equal
numbers from village clinics and township health centres.
Patients were also followed up if interesting information relevant
to our study emerged during the exit survey. The purpose of
interviewing doctors was to ascertain their perspectives on the
drivers of antibiotic use and antimicrobial resistance, including
health system incentives and disincentives to prescribe, social
inﬂuences and their views on patient’s needs and preferences
regarding antibiotics. A patient record review and comparison
with our observational data and a study at retail pharmacies were
also carried out.
In this paper, we draw on observational notes of clinical con-
sultations, exit and follow-up interviews with enroled and con-
senting patients and in-depth interviews with health care facility
staff. Table 1 provides a breakdown of the patient sample and
Table 2 provides numbers for each dataset by site. Results from
the microbiological sampling, pharmacy study and record review
are reported elsewhere.
Data were initially recorded onto datasheets either manually or
into laptop computers and were then uploaded into an online
database at the end of every working day. Quantitative data from
the exit survey was subsequently extracted into Microsoft Excel
ﬁles and descriptive statistical analysis undertaken. Qualitative
data was analysed thematically using a data-driven approach,
with initial coding categories developed by the whole team of
researchers responsible for the social science component of the
project, using bilingual (English and Mandarin) transcripts for a
small number of interviews and observations of the medical
encounter. For each dataset, team members initially developed
code labels independently and then developed an agreed bilingual
code list through discussion and consensus. These code labels
were then applied to all the interview transcripts and observa-
tional notes (in Mandarin) in that dataset using NVivo by
members of the team who had been responsible for collection of
those data and used to produce summary descriptions across
transcripts. Themes were developed iteratively from multiple
Table 1 Recruited patients by site and facility type
Site Total Township health centre Village clinic
Site 1 160 51 109
Site 2 528 375 150
Site 3 345 212 133
Total 1030 638 392
Table 2 Participants by data type
Dataset Site 1 Site 2 Site 3 Total
Patients observed 160 525 345 1030
Exit survey 160 525 345 1030
Patient interviews 8 30 21 59
Physician interviews 4 10 17 31
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views of the coded data and ﬁnalised through discussion and
consensus.
The structure and economy of rural health care
China operates a ‘four tier’ government healthcare system within
which village clinics and township health centres are the lowest-
level health care facilities; above this is the county hospital, and
then large public and private hospitals in major urban centres.
Individual patients may be referred from village or township
facilities to the county hospital, but patients may choose to go
directly to the outpatient department of any health facility. Health
insurance systems provide limited cover only within the county
and province where they are registered as resident and enact a
10–20% decreasing reimbursement ratio for direct medical
expenditures incurred at primary care settings upward (Klotz-
bucher et al., 2010; Xu et al., 2009).
Each township health centre has both inpatient and outpatient
facilities and oversees the public health functions of satellite vil-
lage clinics, which operate on an outpatient basis only. The
number of attending medical staff depends on the population size
of each settlement. Township health centre (henceforth THC)
doctors have formal medical training (a 5-year university degree)
and their salaries and pensions are covered by the county-level
government. However, interviews with the THC director and
doctors in our ﬁrst two ﬁeld sites revealed that 70% of staff salary
comes from government, while the remaining 30% depends on
the ﬁnancial performance of the individual THC.
Village clinics (ofﬁcially designated ‘health service stations’)
were incorporated into the national health service in 2008–2010
under medical reforms to integrate rural health management,
when private clinics were abolished or converted into these ofﬁ-
cially sanctioned facilities (Fang, 2014). Many doctors working at
today’s government village clinics used to practice medicine
privately. Some senior staff were originally ‘barefoot doctors’ who
received only basic training but, over time, became private
practitioners after the breakdown of the commune system in the
early 1980s (Crozier, 1976; Zhang and Unschuld, 2008; Jin et al.,
2011). Since 2009 county governments have been training addi-
tional staff and rural doctors are now required to possess a
medical diploma (zhongzhuan; see Table 3 for a glossary of terms
in Chinese and English) gained after 3 year’s medical training at a
vocational college (Fang, 2014).
Institutionally, village clinics (henceforth VC) are managed by
the local THC but are ﬁnancially semi-autonomous. Usually
located in an administratively deﬁned village or at a site bordering
a couple of administrative villages, VC buildings and basic
equipment are provided by government, but each clinic must
generate income to cover overheads and operational costs, from
disposable needles to electricity bills. The ﬁnancial status of vil-
lage clinic staff is thus much less secure than those at the THC.
The village doctors receive no government salary and acquire
pension rights only after 15 years of continuous service.
By 2017 when our ﬁeld research began, the New Rural
Cooperative Medical Scheme (NRCMS), launched in 2003, pro-
vided almost universal coverage for the agricultural population in
the study areas and 87.4% of the 1030 patients recruited into our
study were covered by the NRCMS. The scheme is a mixture of
user contribution and government subsidy whereby each member
pays an annual fee of 180 Yuan (£20), while the provincial and
local government contribute another 70–80%, about 450 Yuan
(£50). Membership is veriﬁed by presentation of the member’s
second-generation national ID card which has an integrated
circuit chip that can be read automatically by an electronic card
reader at any health facility. This technology plays a signiﬁcant
role in generating patient records and accessing reimbursement
through the system. With a national ID card, a proportion of the
patient’s medical expenses are covered by NRCMS and the rest
must be paid out of pocket. The exact proportion depends on
factors including whether they are outpatient or inpatient, the
type of diagnosis received, and the number of outpatient visits
made in the past year.
The consultation process at rural health facilities
Consultations at both THCs and VCs are offered on a walk-in
basis without appointment. At the THC (Weisheng Yuan, literally
the Hygiene Courtyard), outpatient consultation rooms are
usually the ﬁrst few rooms on the ground ﬂoor of the building
complex that makes up the THC, immediately accessible to
outpatients as they enter. Labels outside the consultation rooms
indicate their focus and patients self-select which one to enter.
Most patients with symptoms associated with possible upper
respiratory tract infection (RTI) (coughs, colds, sore throat) or
UTI come to the “Internal Medicine” (neike 内科), or
“Chinese–Western Combined Internal Medicine/Paediatrics”
(zhongxi yi jiehe neike/erke 中西医结合内科/儿科) consultation
rooms, so this is where our researchers were stationed. The areas
for tests and for intravenous (IV) treatment may be located on
another ﬂoor or in a different building.
Table 3 Glossary of terms
Chinese Pingying English
村卫生室 Cun weishengshi Village clinic (VC)
乡镇卫生院 Xiangzheng
weisheng yuan
Township Health Centre (THC)
药店 Yaodian Pharmacy, medicine shop








抗生素 Kangsheng su Antibiotic, literally “anti-life
element”
抗菌药 kangjun yao Anti-bacterial medicine
抗微生物药 kang weishengwu
yao
Anti-microbe medicine or anti-
microorganism medicine
消炎药 xiaoyan yao Anti-inﬂammation medicine
炎 yan Inﬂammation
中药 zhong yao Traditional Chinese
Medicine (TCM)
西药 xi yao Western medicine
感染 ganran Infection
咽喉炎 yanhou yan Throat inﬂammation
支气管炎 zhiqiguan yan Bronchus inﬂammation
感冒药 ganmao yao Cold remedy
头孢 toubao Cephalosporin
黄芪 huangqi Astragalus (a kind of herb used
in TCM)
消炎水 xiaoyan shui Anti-inﬂammation water or water
that eradicates inﬂammation
(intravenous antibiotic drip)
尿路感染 Naiolu ganran Urinary tract infection
吊水 diaoshui Water for dripstand
尿道炎 niaodao yan Urinary tract inﬂammation
扁桃体炎 biantaoti yan Inﬂamed tonsil
血常规 Xue changgui Routine blood test
血象高 Xuexiang gao High blood cell (count)






New Rural Cooperative Medical
Scheme (NRCMS)
中专 zhongzhuan Medical diploma
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Patients and their companion(s), if any, simply walk into the
consultation room and wait to see the doctor, sitting on the
wooden bench or standing. At peak hours in the morning it is
common to see 6–10 people waiting in the room. Conversations
between patient and physician are easily heard by other patients
(as well as by our researchers sitting opposite the physician’s
desk). Occasionally when there are sensitive issues, the physician
and a patient leave the room to talk in low voices in the corridor
outside to avoid being heard. A single consultation episode
typically sees a patient leaving and returning to the consultation
room at least twice, to pay for and have tests done if ordered by
the doctor before returning with the results, then to pay for and
collect medicine before again returning to the doctor for
instructions. A patient often has to walk back and forth several
times between cashier, in-house pharmacy, test room and con-
sultation room, some on different ﬂoors or in different buildings,
so that a consultation episode can take the whole morning,
though actual physician–patient contact time overall adds up to
probably no more than 10 minutes.
Consultation procedures at the VC are more straightforward.
The building is a simple single-storey structure, usually with three
main rooms. Doctors see patients in a walk-in consultation room,
the pharmacist is stationed in the neighbouring room and the IV
treatment room is next door. No blood or other diagnostic tests
are available. Depending on the size of the village population and
the number of long-term residents, the number of doctors varies
from one to ﬁve. At single-practice clinics, the physician also
occupies the various roles of cashier, medicine dispenser/phar-
macist, IV treatment administrator, home patient health visitor,
electronic record and public health record keeper for the village-
registered population. For clinics with three or more staff mem-
bers, a general division of labour can be seen, although this is not
strictly maintained. An automatic ID card reading machine is
connected to the computer and payment is taken in the
consultation room.
At the VC, the doctor(s) usually get to know most patients
from the village and surrounding areas. They were often born and
grew up in the same local area where they—and sometimes their
parents or grandparents—have practised medicine for decades. At
one of the study VCs, the ﬁrst thing some male patients would do
on arriving at the clinic was to present a cigarette to the doctor, as
a socially appropriate gesture of acquaintance and respect. The
data presented in the following sections come from observation
notes made during everyday consultations in the THC and VC in
our ﬁeld sites.
Antibiotic discourses in health care encounters
In the rural areas where our research took place, a range of
antibiotics are available from both health facilities and retail
pharmacies. We found that antibiotics were frequently prescribed
to patients presenting with symptoms (cough, sore throat, uri-
nation problems) that may indicate a RTI or UTI.
Table 4 shows that nearly 90% of patients with these conditions
who were consecutively recruited into our microbiological study
from six VC and THC, were prescribed antibiotic-containing
treatment, through either or both oral or intravenous routes. How
‘appropriate’ these speciﬁc prescriptions were is, as elsewhere,
almost impossible to determine. Even where microbiological
conﬁrmation is available, tests for RTIs are unreliable; the cau-
sative relation between any cultured pathogen and the presence of
symptoms is difﬁcult to establish. No directly comparable
breakdowns on rates of antibiotic prescribing for RTIs/UTIs are
available for China. National reported averages from 2008 for all
antibiotic prescriptions indicate that 57% of prescriptions from
primary care facilities contained antimicrobials and 39% included
antimicrobial infusions (Center for Health Statistics and Infor-
mation, 2008, cited in Cui et al., 2017) A 2010 report based on
national surveillance data suggested that on average 60% of
outpatients were prescribed antibiotics (H. Xi et al., 2012, cited in
Wang et al., 2017). The latter proportion compares with estimates
for the UK that 39–60% of consultations for RTIs in primary care
receive antibiotics (Gulliford et al., 2014). (NICE guidelines
recommend that all UTI patients—who comprised only 0.25%
(26/1033) of our sample—receive antibiotics). Clearly rates of
antibiotic prescribing should ideally reﬂect rates of bacterial
infection and in this relatively poor, rural population the pre-
valence of common bacterial infections may well be higher than
that seen in more afﬂuent areas, whether in urban China or the
UK. However, for almost 90% of patients reporting RTI symp-
toms to have an infection of bacterial origin would be unusual.
The following analysis unpacks verbal representations of ‘anti-
biotic’ that may go some way to explaining the preferment of this
form of therapy.
The word ‘antibiotic’ has several possible renderings in Man-
darin (see Table 3). Two formal terms, “kangsheng su” and
“kangjun yao” are used in ofﬁcial policy documents relating to
antimicrobial use and AMR. Kangsheng su (抗生素 literally “anti-
life element”) is the abbreviation of the literal translation of ‘anti-
biotic’ but is rarely used in patient–doctor consultations. Kangjun
yao (抗菌药) can be translated as “anti-bacterial medicine”
(implicitly referencing biomedicine) and this term again is
infrequently used in everyday communication between physicians
and patients, though it is the preferred term for medical pub-
lications and ofﬁcial guidelines on antibiotics.
In government outpatient clinics the most commonly pre-
scribed antibiotics are Amoxicillin and Cephalosporin. They
appear in the Ministry of Health’s National List of Essential
Medicines (Health Ministry, 2012) under the category of “anti-
microbe medicine” or “anti-microorganism medicine” (kang
weishengwu yao 抗微生物药). In clinic settings however,
cephalosporin and penicillins such as amoxicillin are generally
described by both practitioners and patients either by name or as
“xiaoyan yao” (消炎药, literally, ‘anti-inﬂammation medicine’).
In semi-structured interviews, most healthcare professionals
claimed to use “xiaoyan yao” and “kangsheng su” inter-
changeably. Others said they use the former to enable commu-
nication with patients:
“I would say ‘xiaoyan yao’ (anti-inﬂammation medicine) to
refer to ‘kangsheng su’ (antibiotics) so that the patients can
understand.” “I use the term ‘kangsheng su’ with insiders
from our hospital” (THC doctor, site 1).
A doctor at a VC whose main duty is to dispense medicine at
the in-house pharmacy said that when talking with other physi-
cians he would use the scientiﬁc term kangsheng su (antibiotics),
“otherwise I would be laughed at for using the unprofessional
term xiaoyan yao (anti-inﬂammation medicine).” To explain why
he uses the latter with patients, he stated that “they do not know”,
referring to rural residents’ “ignorance”. This is echoed by
another village doctor who commented, “I will say the speciﬁc
Table 4 Types of treatment received by recruited patients
(directly observed, n= 1030)
Treatment methods (RTI/UTI) N % of patients
IV antibiotics 473 51.6
Oral antibiotics 692 67.2
Traditional Chinese medicine 10 1.0
Other 59 5.6
IV & oral antibiotics 134 13.0
IV or oral antibiotics 916 88.9
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medicine name, rather than this type or that type. If you said anti-
bacterial medicine (kangjun yao) or antibiotics (kangsheng su)
they would not understand”.
These claims are veriﬁed by analysis of observational notes of
184 doctor–patient consultations that were recorded in two VC
and the four outpatient consultation rooms in three different
THC over a total of 12 months (~4 months in one site). In site 2
THC Room One, where seven physicians rotate attendance in
turn, the term “xiaoyan” (anti-inﬂammation) was recorded 27
times while “yan” (inﬂammation) was noted 113 times; in Room
Two where two physicians rotate in turn for 3-day shifts, “xiao-
yan” is recorded 16 times, with “yan” mentioned 55 times. In
neither room, by contrast, was the formal term “kangsheng su”
recorded at all throughout the observation period. Over the same
period in one VC, “kangsheng su” (antibiotics) was spoken once
by a patient and only a couple of times by a physician during
consultations. In the local institutional and social-economic set-
ting of these rural health facilities, ‘antibiotics’ (抗生素, kang-
sheng su) are thus rendered as a form of ‘anti-inﬂammation
medicine’ (消炎药 xiaoyan yao) by local medical practitioners
and their patients; indeed, this term is widely understood in
ordinary settings simply to mean ‘antibiotic’ and is conventionally
translated as such.2
Infection as inﬂammation. The literal translation of “xiaoyan
yao” or “antibiotics” is “medicine/drug that eradicates or reduces
inﬂammation”. It consists of three characters, with the third
character yao (药) being a generic term that refers to drug or
medicine; for example, “Western medicine” is translated as “xi
yao” (西药) and traditional Chinese medicine (TCM) as “zhong
yao” (中药). The ﬁrst two characters “xiaoyan” (消炎) are
composed of xiao (消), a verb that can be translated as “to
remove, or to eradicate”, while yan (炎) is a noun that is generally
translated as “inﬂammation”. “Yan”, inﬂammation, denotes a
concept that is common to popular understanding, TCM and
biomedicine. In Chinese, the character “yan” (炎) is composed of
two simple characters for ﬁre (huo 火), readily establishing the
connection between “yan” (inﬂammation) and symptoms of
redness, heat and swelling that in Chinese medicine are indicative
of a ‘hot-natured state’ (Otsuka, 1976) and in popular under-
standing, of ‘hot’ conditions (Farquhar, 2013); just as for English
speakers, ‘inﬂammation’ has obvious connotations of redness and
heat through its etymological roots in ‘catching ﬁre’. “Xiaoyan” in
turn is a combined word used as an adjective to mean “anti-
inﬂammation” or as a verb to mean “to eradicate inﬂammation”.
In biomedical terminology, the character “yan” is often used as a
sufﬁx to a speciﬁc body part or body location to indicate the
presence of infection (ganran in Chinese 感染) in an equivalent
manner to the English sufﬁx “-itis”. Thus, yanhou yan (咽喉炎)
literally, “throat inﬂammation”, means pharyngitis; zhiqiguan yan
(支气管炎), literally, “bronchus inﬂammation”, is translatable as
bronchitis. Yan alone is often used to describe a condition where
there is redness, heat and/or swelling such as sore throat or fever,
but also where a blood test has indicated a high white blood cell
count (see below).3
When a patient’s symptoms indicate “yan” (inﬂammation),
antibiotics, as “xiaoyan yao”, denoting medicines that will
remove inﬂammation, clearly indicate the prospect of effectively
treating these symptoms more directly than either “kangsheng
su” (anti-life element 抗生素) or “kangjun yao” (anti-bacterial
medicine 抗菌药). In the next section we summarise three
clinical encounters to demonstrate how patients (P) and doctors
(D) co-construct the use of antibiotics as appropriate for the
treatment of common conditions indicative of inﬂammation in
clinical consultations.
Co-construction of appropriate treatment for common infec-
tions. A 65-year-old male (2-1-20171110-01X) came in to a THC
to ask for a cold remedy (ganmao yao 感冒药):
P: Help me, prescribe some cold remedy (ganmao yao感冒药)
D: Cold remedy? For who?
P: For me
D: Prescribe some for cold and some ‘to reduce inﬂammation’?
(开点感冒的开点消炎的)
P: Prescribe something to ‘reduce inﬂammation’ (开点什么消
炎的)
D: You look, cephalosporin (toubao 头孢)
P: Prescribe more huangqi [a TCM 黄芪]. How many are you
prescribing?
D: Two packs of cold remedy; two packs of “xiaoyan yao”
(medicine that eradicates inﬂammation) (感冒药开2盒消炎药开
2盒)
When this patient demands a ‘cold remedy’ the physician
spontaneously also offers antibiotics, which the patient assents to.
The physician then speciﬁes that he is prescribing cephalosporin,
at which point the patient also requests a type of TCM that is
thought to strengthen one’s energy (qi). This exchange demon-
strates that both physician and patient recognise cephalosporin as
a type of antibiotic (“xiaoyan yao”, anti-inﬂammation medicine);
that “xiaoyan yao” is useful for treating “cold” (ganmao); and that
xiaoyan yao differs from non-antibiotic ‘cold remedy’ (ganmao
yao). Moreover, it illustrates a form of exchange that we found to
be common in clinical encounters, whereby doctors sponta-
neously prescribed antibiotics when presented with symptoms or
self-diagnoses indicative of inﬂammation.
A 17-year-old male patient (2-1-20171106-03Y) came to the
general medicine outpatient clinic at the THC and told the
attending physician that he had tonsillitis (biantaoti fayan 扁桃
体发炎, lit.“tonsil inﬂammation”) with pain on swallowing. He
said he had taken some amoxicillin and banlan gen (板蓝根 a
type of processed TCM for making a drink) the night before, but
it was “no use”. The doctor did not comment on his self-
medication but examined the patient’s throat with the aid of a
torch and commented that “the swelling is not so bad”. The
patient responded that it was sore and asked whether a ‘drip of
water’ (diaoshui, IV treatment—see footnote 2 and Table 4)
would be necessary. The doctor replied that a drip was not
recommended and said he would prescribe some medicine ‘for
cold’. The electronic patient record shows the medicines
prescribed as two packs of oral amoxicillin (an antibiotic), one
pack of qingkailing granule (for making a TCM drink); and one
bag of paracetamol pseudoephedrine tablets (for pain relief).
In a third case, a 21-year-old woman (2-1-20171021-01T)
came to one of the THCs complaining of a cough. The physician
said, “I will dispense you a pack [of medicine] to stop coughing,
and a pack of “something that eradicates inﬂammation” (消炎
的)” and prescribed ambroxol hydrochloride tablets and
amoxicillin tablets for oral intake. What appears to be important
to patients, conﬁrmed in the patient interviews, is to obtain
medicines that perform a speciﬁc function in alleviating their
symptoms—in this case, antibiotics for reducing or eradicating
inﬂammation. Likewise, residents of a Sichuan village are said to
recognise speciﬁc drugs they were given by their function rather
than their name (Lora-Wainwright, 2005).
In interviews, the doctors in our study sites talked about
patient demand as a reason for prescribing antibiotics. Some
explained that they ﬁnd it difﬁcult to refuse patients’ requests,
either due to the need to maintain a good relationship with
patients or for fear of losing patients to other doctors. However,
our observations of consultations, as illustrated in the above
encounters, demonstrate that the prescribing of antibiotics for
conditions characterised by “inﬂammation” is often initiated by
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doctors rather than patients. One critical reason for these
concerns to meet perceived patient expectations is ﬁnancial, as
the “business volume” of patients is related either directly (in the
case of village doctors) or indirectly to their income. That patient
demand may be a less important driver of prescribing practice
than doctors report is supported by evidence from a recent
population survey in the same geographical region as our study
area. The survey found that contrary to popular assumptions
within the medical profession, only a small minority (0.25%) of
people reported having requested speciﬁc prescriptions when
consulting a doctor and most expressed no concerns about
leaving a consultation without a prescription (Cheng et al., 2018).
Symptoms and technologies in the diagnostic process. The
previous section demonstrated that presence of “yan” (inﬂam-
mation) is usually followed by a prescription for antibiotics
(xiaoyan yao). At lower level health facilities in China there is no
microbiological support for culturing specimens or for antibiotic
sensitivity testing; the THCs have laboratory facilities only for
basic urine and blood tests and the VCs have no laboratory,
although samples may be sent away to the county hospital in
unusual cases. This section explores the interpretation of symp-
toms and blood test results to inform decision making relating to
diagnosis and antibiotic prescribing. It also demonstrates the
complex process whereby “yan” (inﬂammation) and “xiaoyan”
(anti-inﬂammation) have come to occupy a semantic register
which encompasses ‘infection’.
In both THC and VC, the criteria most frequently used by
doctors to indicate “inﬂammation” (yan) are fever, a red or
swollen throat or tonsils, or a high white blood cell count
(indicating a strong immune response). Patients attending the
THC who complain of cough and a sore or itchy throat are
commonly told to obtain a blood test and an X-ray. They usually
return to the consultation room with the results within half an
hour. The case of a 55-year-old female patient (2-1-20171107-
04N) exempliﬁes this process. She was accompanied by two
family members and after an initial brief consultation, the
physician ordered a blood test for her. The following conversation
was recorded after the patient returned with her blood test result
and showed it to the physician:
D: White blood cell is 3 plus (白细胞3个+). This is typical
urinary tract infection (尿路感染)
Patient companion (PC): What does that mean?
D: White blood cell [count] indicates there is inﬂammation (白
细胞说明有炎症).
PC: So that is severe (那很严重)
D: It will be ﬁne with a drip [lit. some ‘hanging water’ (吊点水
就好了)]. Drink more water and come tomorrow morning
without eating anything for another blood test. Take this
[hospitalisation note] to the nurse.
In this exchange, the physician diagnoses a UTI based on the
blood test result of an elevated white blood cell count, using the
term “ganran” (infection). When the patient’s family member
asks for clariﬁcation the physician switches to the term “yan”
(inﬂammation), describing the problem as “urinary tract
inﬂammation” (niaodao yan 尿道炎), which is construed as
serious. The physician then prescribes intravenous (IV) anti-
biotics and hospitalises the patient. In the electronic record, the
physician records the diagnosis as “urinary tract infection”
(niaodao ganran) and prescribes three types of antibiotic:
ceftriaxone and levoﬂoxacin for intravenous infusion, and
erythromycin for oral use, as well as qingkailing tablets (a type
of OTC TCM).
Patients as well as doctors interpret symptoms such as redness
and swelling as indicative of “yan” (inﬂammation) and hence as
appropriately treated with antibiotics (“xiaoyan yao”), as
exempliﬁed by the following consultation at a THC in which a
41-year-old female patient (2-1-20171110-02Y) demands anti-
biotics for a condition associated with inﬂammation:
P: Prescribe [me] ‘xiaoyan yao’ (开消炎药). My throat is
swollen (喉咙肿了).
D: (examining throat with a torch) It is swollen.
P: I had it since last night and it doesn’t get better with
drinking more water.
D: Are you allergic to any medicine?
P: No. Is this tonsil inﬂamed or throat inﬂamed? (这是扁桃体
炎还是咽喉炎)
D: Tonsil is not swollen. Throat inﬂammation. Talk less. (扁桃
体不肿, 咽喉炎, 少讲话)
P: [It has been] over a month
D: Talk less. You must talk less with throat inﬂammation (咽喉
炎必须少讲话)
The diagnosis recorded electronically was “nose and throat
inﬂammation (yanhou yan 鼻咽炎/咽炎)” and two packs of
dirithromycin (an oral antibiotic) and a pack of OTC processed
TCM banlangen particles were prescribed.
The role of blood tests as a means of indirectly ascertaining the
presence of infections presumed to be bacterial and hence as
warranting antibiotics is illustrated by the experience of a 60-
year-old woman (2-1-20171023-01T) who complained of a cold
(感冒) and fever:
D: [looking at thermometer] Fever, 37.7, low fever. Have you
got your ID card?
P: I do
[The doctor then ordered a routine blood test 血常规]
D: Go get a blood test. Come back here afterwards.
[The patient returned in 12 min with the blood test result]
D: The blood cell is high; your white blood cell is high (血象高
了, 白细胞高了), do you cough?
P: Cough
D: [examines throat] The blood cell is high; it should be
bacterial infection (血象高, 应该是细菌感染). Do you have any
phlegm?
A diagnosis of bronchitis (lit.’bronchus inﬂammation 支气管
炎’) was recorded and IV cefoxitin (a second-generation
cephamycin antibiotic), intravenous vitamin C and pseudoephe-
drine tablets were prescribed.
Experiences like this indicate to the patient that a blood test
can indicate the presence of inﬂammation (yan), reinforcing an
elision between inﬂammation and infection and providing
scientiﬁc legitimation to the appropriateness of antibiotics for
treating symptoms of inﬂammation.
Varieties of knowledge in biomedical practice: Pathogenicity
and terminology
The training and qualiﬁcations of doctors in village and township
health facilities are quite variable, but all those who staffed the
clinics where we carried out our study were aware that antibiotics
are clinically indicated only for bacterial infections. In interviews,
these doctors claimed to use the term “inﬂammation” (yan) in
place of “infection” (ganran) simply in order to be more readily
understood by patients. This is illustrated in the above con-
sultation episode (2-1-20171107-04N) where the patient’s relative
asked about the meaning of urinary tract “ganran” (infection) and
the doctor switched verbally to “inﬂammation” (yan), but still
entered “infection” (ganran) in the patient’s electronic record.
However, comparison of other patient records with observed
cases and closer examination of biomedical language indicates
that this explanation does not adequately account for dis-
crepancies between verbal characterisation and written diagnosis.
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Rather, we found that “infection” and “inﬂammation” are not
systematically distinguished within the biomedical vocabulary
used in clinical practice and hence that bacterial infection logi-
cally constitutes a form of “inﬂammation”. For example, in the
subsequent case above (2-1-20171023-01T), the doctor told the
patient, “The blood cell count is high; it should be bacterial
infection” but the electronic record states, “bronchus inﬂamma-
tion (zhiqiguan yan支气管炎)” rather than “bronchus infection”.
In a similar case (2-1-20171029-02T), the doctor gave a verbal
diagnosis of “windpipe infection” (zhiqiguan ganran 支气管感
染)” but recorded a diagnosis of “bronchus inﬂammation (zhi-
qiguan yan 支气管炎)” in the electronic patient record. The
reason for this is that zhiqiguan yan 支气管炎 is in fact the
conventional translation of ‘bronchitis’ in Mandarin and is a
standard diagnostic category used in electronic medical records.4
Crucially, this is not a simple matter of local misapprehension
or mistranslation, for ‘inﬂammation’ is not in itself more or less
appropriate a descriptor than ‘infection’ in physiological terms. In
conventional northern European biomedical parlance, the word
‘inﬂammation’ has come to be used solely to describe discernible
conditions of inﬂammation excluding those caused by bacterial
infection, such as osteoarthritic conditions; hence the character-
isation of non-antimicrobial medicines such as steroids and
ibuprofen as ‘anti-inﬂammatories’. This language convention
itself illustrates the special place that the microbe as disease-
producing has come to occupy in European pathogenicity.
However, bacterial infection can (and often does) produce
inﬂammation—just as inﬂammation can be (but is not always) a
consequence of infection.
Indeed, the potential role of inﬂammation as an immunological
indicator of bacterial infection is rapidly gaining prominence and
various tests of inﬂammatory markers, such as C-reactive protein
(CRP), are being explored as potential rapid point of care tests for
bacterial infection (Aabenhus and Jensen, 2016; Beisel et al., 2016;
Haenssgen et al., 2018; Zaw et al., 2018; Little et al., 2013). Our
primary focus here is not the use of technologies in healthcare
settings, but social analyses that draw on actor network theory to
conceptualise testing technologies as evolving along with their
local context (Beisel et al., 2016; Haenssgen et al., 2018; see also
Chandler et al., 2008) resonate with our observations on how
blood tests are used in THCs. CRP is advocated as a measure to
reduce ‘irrational’ antibiotic prescribing in primary care settings
by providing a tool for doctors to determine when antibiotics are
not needed. It has been shown to reduce prescribing, perhaps not
because (as assumed by rapid test developers) it is an accurate
marker of bacterial infection, or because (as assumed by general
practitioners who use the test) a negative result convinces patients
that they do not need antibiotics, but because it inﬂuences doctors
not to prescribe antibiotics and provides evidence to defend their
decision to patients (Tonkin-Crine et al., 2016). In rural China,
where (unlike most European primary care settings) rapid point
of care blood tests are available in township health facilities, white
cell counts are being used for similar social reasons, but for the
purpose of justifying prescribing. Whether or not such tests are
accurate or appropriate as a decision support tool for antibiotic
prescribing, the logic underlying their use for clinical decision-
making is not inconsistent with immunological understandings of
the cellular response to infection. The distinctive difference
between these two characterisations of pathogenicity is in their
differing emphases on the roles of causative agent and bodily
reaction (or ‘host response’); in the diagnostic milieu of European
primary care, therapeutic decisions focus on causal attribution of
the illness to a bacterial or non-bacterial pathogen whereas in
these ﬁeld settings, the primary therapeutic focus is on the
inﬂammatory response.
Pathogenicity and infection: Accommodating Chinese and
biomedical knowledges
Since the early years of the People’s Republic, China’s health care
system has been ofﬁcially plural. The political history of relations
between Chinese traditional medicine and Western biomedicine
is a complex one and can only be touched on here; research on
Asian medical systems e.g. (Leslie, 1976; Leslie and Young, 1992)
has demonstrated how indigenous traditions often become har-
nessed to wider nationalist ideologies. From the early 20th Cen-
tury “Western” biomedicine was widely embraced as a tool of
scientiﬁc progress and modernity (Unschuld, 1992), while Chi-
nese medicine has occupied an ambivalent position as both a
‘particularly noxious symbol’ (Crozier, 1976, p. 342) of backward
tradition and an important marker of cultural identity (see also
Farquhar, 1995). Historians of Chinese medicine have traced the
contemporary form of TCM to the 1950s, when Chinese medicine
was promoted under Mao Zedong through a series of initiatives
ultimately aimed at integrating the two traditions (Scheid, 2013,
pp. 251–253; Scheid and Hsiang-Lin Lei, 2014). The model that
underpins contemporary TCM, “pattern differentiation and
treatment determination” (bianzheng lunzhi), sometimes shor-
tened to ‘pattern diagnosis’, was codiﬁed in this period as being
deﬁnitive of Chinese medical practice.5
Historically, boundaries between diseases, symptoms and pat-
terns were not consistently delineated in Chinese medical theory.
Within biomedicine too, the advent of germ theory marked an
increased emphasis on cause and relatedly, disease speciﬁcity. In
China infectious diseases (chuanranbing) were ofﬁcially recog-
nised in the early 20th century following the Manchurian plague
epidemic. By implication, the acceptance of germ theory and of
microbiological laboratory analysis for diagnostic purposes pre-
sented a potential challenge for commensurability between Chi-
nese medical and biomedical nomenclature and the incorporation
of germ theory into Chinese medicine. It may have been the
biomedical deﬁnition of diseases as associated with speciﬁc causal
pathogens that actually initiated the reconceptualization of Chi-
nese medicine as focusing on ‘pattern’ rather than ‘disease’, and
on treatment rather than aetiology (Hsiang-Lin Lei, 2014, pp.
168–192). Determining treatment according to ‘pattern differ-
entiation’ rather than aetiological deﬁnition provided a means for
Chinese medicine to differentiate itself from biomedicine and to
offer practical therapeutics while avoiding confrontation between
the distinct and potentially incommensurate ontologies of Chi-
nese medicine and biomedicine.
One of our interviewees, a dual practitioner of TCM and
biomedicine, points towards processes of accommodation
between Chinese and biomedical approaches to the practice of
clinical medicine that support this reading. This VC doctor has
TCM training and has been practicing for over 40 years. He is
popular locally and dispenses both TCM herbs and biomedicine,
including antibiotics. When asked about his diagnostic decision-
making and selection of medicines, he responded, “If I am going
to dispense TCM, I will give a Chinese medical diagnosis; if I am
going to dispense Western medicine, I will give a Western medical
diagnosis.” Field notes on this doctor’s consultation practices
indicate that for similar symptoms, he would record the diagnosis
as “windpipe inﬂammation” when dispensing TCM and “wind-
pipe infection” when dispensing antibiotics. The same doctor also
commented that “TCM can also be used to ‘eradicate inﬂamma-
tion’ (xiaoyan)”. Indeed, currently there is considerable interest
among TCM researchers, as well as the educated public, in the
potential for identifying “natural antibiotics (tianran kangshengsu
天然抗生素)” from TCM products or herbs (Yuan, 2013).
The effects of what we are describing as accommodation rather
than displacement can be seen in the diagnostic processes
ARTICLE PALGRAVE COMMUNICATIONS | https://doi.org/10.1057/s41599-019-0293-y
8 PALGRAVE COMMUNICATIONS |            (2019) 5:85 | https://doi.org/10.1057/s41599-019-0293-y | www.nature.com/palcomms
described earlier, while there has been a gradual shift towards
prioritising the biomedical diagnosis in medical institutions
(Yuan, 2013, pp. 254–255). It is important to note that only a
minority of the doctors working in our THC and VC study sites
were also trained TCM practitioners. However, Chinese medical
precepts such as the recognition of speciﬁc symptoms as indica-
tive of ‘cool’ or ‘hot’ conditions and the therapeutic use of heating
and cooling foods to treat them, are a widespread element of
popular culture (Farquhar, 2013). Accordingly, both patients and
doctors are broadly familiar with a diagnostic process that treats
symptoms as indicative of internal pathological process—in this
case, inﬂammation—rather than of external pathogenic cause
(bacterial infection).
Knowledge hybrids and boundary objects
Globalisation processes bring different cultures of knowledge and
practice into close proximity, resulting in borrowing and incor-
poration of elements between them in a process sometimes
described as hybridisation (Holton, 2000; Frank and Stollberg,
2016; Pieterse, 1994; Lock and Nguyen, 2010). In the social sci-
ences, the concept of hybridity has also been deployed produc-
tively to highlight knowledge conﬁgurations that traverse both
social and scientiﬁc domains, for example the interweaving of
ideas about what constitutes kinship or family with genealogical
information in clinical genetics (Gibbon, 2007; see also Wade,
2005). Biomedical science is both global and plural, while the
‘indigenisation’ of clinical biomedicine into local settings
(Kleinman, 1995, p. 24) produces signiﬁcant diversity of practice,
with widely available therapeutic technologies being deployed in
different ways (Kleinman, 1995), as the above example of blood
tests illustrates.
Sociologists of science have emphasised the ‘patchiness’ of
scientiﬁc culture and its heterogenous composition of material,
conceptual and social elements in practice (Pickering, 1992). In
this case study, the enmeshing of concepts, terms and technolo-
gies of ‘infection’, ‘antibiotics’ and ‘inﬂammation’ - themselves
emerging into biomedical practice from the distinct laboratory
biosciences of microbiology, pharmacology and immunology -
with pre-existing local understandings of internal ‘heat’ - them-
selves emerging from both codiﬁed knowledge contained in
Chinese medical texts and popular conceptions of health relating
to thermal quality - exempliﬁes such hybridisation. Over the past
half-century biomedical knowledge in this setting has been
domesticated, a sometimes contested process by which (in rela-
tion to medical traditions becoming integrated into Western
context), “the foreign is rendered familiar and palatable to local
tastes” (Fadlon, 2004; Cunningham, 1997). In contemporary
practice, through a hybrid construct of inﬂammation–infection
these rural doctors draw on popular understandings of patho-
genicity, as well as the authority of biomedical science.
Our comparative exploration of pathogenicities and the local
language of antibiotics in rural China suggests a historical process
of hybridisation and accommodation whereby inﬂammation (yan
炎) has come to function as a ‘boundary object’ (Star and Grie-
semer, 1989) enabling translation between local understandings
of person-speciﬁc bodily illness, immunological processes and
microbiological conceptions of bacterial infection. Initially con-
ceived to explain how people with diverse disciplinary back-
grounds and social agendas manage to coordinate consensus in
scientiﬁc work (Fujimura, 1992), ‘boundary objects’ may be
concepts, material items or methods that facilitate translation
across different social worlds. They emerge where the work of
multiple groups intersect, not by design but through the char-
acteristics of being adaptable enough to carry different meanings
and fulﬁl different local needs, while having a sufﬁciently robust
structure to be collectively recognisable to all social actors. Once
produced, these boundary objects, ‘react back upon the social
worlds thus linked… reconstituting the very objects of study, as
well as the material, conceptual, and social practices that sur-
round them’ (Pickering, 1992, p. 13). Seen in this way it is
apparent how ‘inﬂammation’ does not just reﬂect, but has come
to orient and shape, both local treatment-seeking practices and
clinical conventions.
Knowledge, education and social change: Implications for
tackling AMR
We have suggested that the local interpretation of pathogenicity,
as foregrounding the treatment of inﬂammation by ‘anti-
inﬂammatory’ drugs over the ‘anti-biotic’ extermination of (pre-
sumptive) bacterial pathogens, may help to account for the high
frequency of resort to antibiotics in treating common RTI and
UTI symptoms that we observed in our study clinics. This is just
one of many issues contributing to shape current patterns of
antibiotic use that for reasons of space we have only been able to
touch on here, such as institutional and economic drivers that
include systems incentives and payment arrangements within the
healthcare system. In addition to these important determinants of
antibiotic prescribing are broader social structural inﬂuences on
antibiotic consumption, including the desire for fast treatment
(cf. Vuckovic, 1999) in a setting where agricultural workers can ill
afford time off work and high rates of labour migration mean that
precious single children are often left in the care of elderly
grandparents (Cheng et al., 2018). Many of these determinants
have been highlighted elsewhere (e.g. Reynolds and Mckee, 2009;
Jin et al., 2011; Sun et al., 2015; Currie et al., 2011), whereas, to
our knowledge, antibiotic discourses and their conceptual foun-
dations have not previously been documented.
This analysis has pointed to the semantic complexities entailed
in unravelling patterns of antibiotic use in the treatment of
common health problems among patients attending rural health
facilities in China. Our empirical ﬁndings may have limited
generalisability to other settings, particularly China’s urban
environments, where medical specialists are concentrated in large
hospitals and sophisticated laboratory support is available to
support the treatment of local populations, many of whom are
highly educated. However, research showing that education is
positively correlated with antibiotic self-medication in China,
suggest that the rates of antibiotic use in our study settings cannot
simply be attributed to lack of biomedical knowledge or low
educational levels. (Bi et al., 2000; Wang et al., 2017; Cheng et al.,
2018). Indeed, a cluster randomised survey of 2600 rural residents
in 12 counties of eastern China that investigated self-reported
health service-seeking and antibiotic consumption, found that
knowledge about antibiotics (what pathogens antibiotics are
effective for and potential risks of using them) is associated with
increased purchasing of over-the-counter antibiotics and with re-
use of existing medication from prior illness episodes (Cheng
et al., 2018). Our ﬁndings regarding local views of antibiotics,
including their characterisation as ‘anti-inﬂammatory medicine’,
the absence of a clear linguistic demarcation between them and
other non-antibiotic anti-inﬂammatories, and their perceived
appropriateness in the treatment of common symptoms of viral,
as well as bacterial, infection, are also consistent with studies
across socioeconomic groups in other provinces of China (Jin
et al., 2011).
Although a previous section highlighted processes of knowl-
edge hybridisation that are socio-historically speciﬁc to China,
research evidence from elsewhere in Asia suggests that our
interpretation of the ways in which clinical practice may be
inﬂected by local conditions in the selection of biomedically
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consistent narratives of pathogenicity may have wider relevance.
The vernacular characterisation of antibiotics as ‘anti-inﬂamma-
tory’ has also been reported from Thailand (Haenssgen et al.,
2018; Zaw et al., 2018) and elsewhere; across Asia and the middle
East, biomedicine exists together with indigenous codiﬁed tradi-
tions of medicine that link health with concepts of internal bal-
ance and include notions of thermal quality (often characterised
broadly as ‘humoral’), so it is likely that similar processes of
hybridisation with pre-existing medical knowledge have occurred
elsewhere. Cross-cultural consistency in local as well as biome-
dical understandings of inﬂammation and its symptoms is plau-
sible because they all draw on metaphors that are based in
physical as well as cultural experience. Metaphors structure
everyday concepts and are reﬂected in language; sensations of
temperature (heat–cold) are fundamental sensory experiences
that provide common grounds for culturally diverse conceptual
elaboration in both science and everyday life (Lakoff and Johnson,
2003 [1980]).
The World Health Organisation Global Action Plan and linked
National Action Plans for tackling antimicrobial resistance
emphasise the importance of ‘public awareness’ and ‘education’ in
reducing inessential use of antibiotics (World Health Organiza-
tion, 2015; Xiao and Li, 2016). Objective 1 of the Global Action
Plan is to, ‘Improve awareness and understanding of anti-
microbial resistance through effective communication, education
and training’ and the plan speciﬁes that, ‘Steps need to be taken
immediately in order to raise awareness of antimicrobial resis-
tance and promote behavioural change, through public commu-
nication programmes that target different audiences in human
health, animal health and agricultural practices as well as con-
sumers’ (WHO, 2015, p. 8). This well-established public health
strategy assumes that ‘communication, education and training’
will ‘improve awareness and understanding’; improved awareness
and understanding will produce changes in individual behaviour;
and individual changes in behaviour will ameliorate the problem.
The emphasis on public education and awareness in national
and global AMR policy postulates that patient demand drives
antibiotic use and that this demand is excessive. However, we
have shown that while local doctors attribute their antibiotic
prescribing practices to patient demand, in practice antibiotic
prescriptions are often initiated by doctors. The tendency for
doctors in general practice to attribute their prescribing of anti-
biotics for conditions that are not clinically warranted to ‘patient
demand’ has been widely documented elsewhere (Nielsen, 2019;
Brookes-Howell et al., 2014; Cabral et al., 2014a; Lucas et al.,
2015). In Europe and Scandinavia, patients’ desire for reassurance
may be (mis)interpreted by doctors as a demand for antibiotics. A
UK study of prescribing showed doctors’ perceptions of patient
pressure to be a consistently stronger predictor of prescribing
than patients’ actual preferences (Little et al., 2004). Whether or
not similar interpretative processes are at play here, the con-
sistency of this ﬁnding across diverse cultural and national set-
tings demonstrates how patient treatment preferences do not
exist in a vacuum but are constructed dialectically through
interaction between health professionals, the institutions through
which medicine is delivered, and those who utilise these services.
Our ﬁndings indicate that if such demand is present among
patients in rural China, it is being co-created by spontaneous
prescribing of antibiotics to patients with complaints such as sore
throat and cold. Through such encounters, patients and the
communities from which they come acquire experiential knowl-
edge that those with medical authority consider antibiotics
appropriate for such conditions. This demonstrates the notorious
‘fallacy of the empty vessels’ (Polgar, 1962) embedded in the
assumptions that underpin many health communication and
knowledge transfer strategies, for in rural China as elsewhere, the
putative targets for education and awareness-raising already
possess salient experiential and informal knowledge (and some-
times formal education) that will be mobilised in the interpreta-
tion of new information, so that educational interventions which
assume ‘empty vessels’ of ignorance are liable to fail. We have
shown that meaningful translation even of the very term ‘anti-
biotic’ implicates a local reading of pathogenicity that renders the
treatment of symptoms of infection by ‘anti-inﬂammation med-
icine’ appropriate; our analysis suggests that attempts to modify
both antibiotic prescribing and consumption practices should, at
the very least, take semantics seriously and consider what anti-
biotics signify locally in designing interventions to modify
their use.
Many current education and communication strategies tar-
geting antibiotic use closely resemble the widely critiqued ‘deﬁcit
model’ of the public understanding of science (Irwin and Wynne,
1996) that assumes a uniﬁed ‘science’ which is deﬁnitively sepa-
rated from the social and in which there is a unidirectional
transfer of knowledge from learned expert to passive recipient.
However, if medical knowledge is actively co-constructed in
practice (Lambert and Rose, 1996), with ‘loop-back mechanisms’
operating between lay and expert, scientiﬁc and indigenous, local
and cosmopolitan knowledges (Edwards et al., 2007, p. 11), then
interventions which take public understanding to be an autono-
mous and discrete realm from scientiﬁc knowledge, or that focus
only on individual cognition, are unlikely to succeed in changing
practices. Moreover, who counts as an expert depends on social
positioning within the health system hierarchy; local doctors who
may be regarded as respected authorities by their patients are not
always regarded as knowledgeable by their professional counter-
parts at higher levels of the healthcare system. The appropriate
content of education and awareness programmes for both prac-
titioners and patients also requires careful examination, given the
complexities of antibiotic use in relation to AMR and (to date)
partial and shifting state of scientiﬁc knowledges regarding
numerous salient issues, from the relative importance of human
antibiotic consumption in AMR transmission, to the appropriate
duration of antibiotic courses in minimising drug resistance.
Community-wide or societal shifts in behaviour cannot
readily be effected through the education of numerous indivi-
duals since collective change is a social process, contingent on
the speciﬁc social, cultural and economic structures upon
which behaviour is predicated (Lambert, 2016) and produced
through continual interactions between political and profes-
sional institutions and civil society actors. The focus on indi-
vidual behaviour change that currently dominates public health
approaches to modifying antibiotic use in order to ameliorate
AMR should be complemented by greater attention to dynamic
and collective processes of knowledge acquisition, the con-
tingent and plural nature of scientiﬁc knowledge, and the
semantic and sociocultural, economic and systems inﬂuences
that shape the actions of health professionals, patients and
publics alike.
Data availability
Following completion of the project in late 2019, all non-sensitive
data will be made available on an open access basis through the
University of Bristol Data Repository and/or the UK Data Service.
Further information is available from the corresponding author
on reasonable request.
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Notes
1 Antibiosis, ‘an association between organisms that is injurious to one of them’ https://
www.dictionary.com/browse/antibiosis); Anti-, ‘opposite, against, in exchange, instead,
representing, rivalling,stimulating’; biotic, ‘Of animal life; vital’ (Oxford English
Dictionary 1971).
2 In an account of ‘over-prescribing’ for colds as common in a village of Sichuang
Province, some prescribed pills are recognised by villagers as xiaoyan yao (消炎药)
which the author translates, tellingly, as ‘medicine for minor infections’ (Lora-
Wainwright, 2005, p. 480).
3 A related phrase is xiaoyan shui (消炎水), “water that eradicates inﬂammation” or
“anti-inﬂammation water”, used by patients to refer to antibiotics that are
administered intravenously. The institutional and popular preferment of intravenous
(IV) treatment is signiﬁed by the inclusion in every clinic of a dedicated infusion room
for giving IV treatment to outpatients. The importance of this kind of medical
intervention may be traced back to its introduction by barefoot doctors with limited
medical training in the 1950s (Li et al., 2012; Huang, 2014), but for reasons of space we
do not address the speciﬁc use of IV antibiotics in this paper.
4 We are grateful to an anonymous reviewer for this observation.
5 In this approach, the physician identiﬁes relevant symptoms and signs as being
indicative of speciﬁc clinical patterns, or diagnoses, which can then be used to guide
treatment strategies. These distinctive patterns can be regarded as similar to
syndromes in biomedicine but rather than deﬁning a disease, they enable the
practitioner to pinpoint the underlying pathological processes of qi (energy)
transformation that give rise to the identiﬁed pattern of symptoms at the point of
consultation (Scheid, 2013, p. 253).
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